Streetbeat News

Stock Prices

CLOV

Clover Health Investments, Corp. (NASDAQ:CLOV) shares have experienced volatility throughout November, with a rally in early November ahead of its Q3 earnings report. The company reported sales of $482.07 million, missing estimates, and an earnings loss of nine cents per share, beating expectations. Despite an initial drop post-earnings, CLOV shares rose 11.1% to $1.00, potentially influenced by positive October CPI data indicating easing U.S. inflation.

Portfolio Pulse from Ryan Gustafson

November 14, 2023 | 8:25 pm

DCBO

Needham analyst Ryan MacDonald initiated coverage on Docebo Inc (NASDAQ:DCBO) with a Buy rating and a price target of $56. MacDonald highlights Docebo's potential to gain market share and deliver growth and profitability in FY24, citing a differentiated product suite and growth initiatives. Revenue and EPS estimates for FY23 are $180.0 million and $0.58, and for FY24 are $221.4 million and $1.09, respectively. Docebo's Q2 FY23 results exceeded expectations with a 24.8% revenue increase and an adjusted EPS of $0.14. DCBO shares rose 9.35% to $51.64.

Portfolio Pulse from Lekha Gupta

November 14, 2023 | 8:20 pm

BLK

Industry lobbyists at the Benzinga Future of Digital Assets conference expressed concerns about the lack of clear cryptocurrency regulations in the U.S. and the predominance of enforcement through the courts rather than proactive guidelines. The FTX scandal's impact on regulatory sentiment was noted, and comparisons were made with clearer regulatory frameworks in the U.K. and EU. Concerns were also raised about misconceptions regarding cryptocurrency's use in illicit finance. Despite regulatory challenges, there is anticipation for a potential Bitcoin ETF approval by the SEC, with companies like BlackRock and Valkyrie awaiting a decision expected in early 2024.

Portfolio Pulse from Neil Dennis

November 14, 2023 | 8:12 pm

PETV

PetVivo Holdings (NASDAQ:PETV) reported a year-over-year decline in Q2 earnings per share from $(0.21) to $(0.28), a 33.33% decrease. Sales also decreased by 7.13% from $223.28K to $207.37K compared to the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:11 pm

AUVI

BCDA

INVO

KBNT

SKIN

THRX

U.S. stocks saw significant gains with the Dow Jones rising over 500 points. Home Depot (HD) reported third-quarter results that exceeded expectations, with a 3% year-on-year sales decline to $37.71 billion, surpassing analyst estimates of $35.66 billion, and an EPS of $3.81 beating the consensus of $3.58. Real estate shares led the market with a 5% surge, while energy shares had a modest increase of 0.5%. BioCardia (BCDA), INVO Bioscience (INVO), and Theseus Pharmaceuticals (THRX) experienced substantial stock price increases due to positive company developments. Conversely, The Beauty Health Company (SKIN), Kubient (KBNT), and Applied UV (AUVI) saw their shares plummet following negative financial results and company announcements.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 8:10 pm

ISPR

Ispire Technology Inc. (NASDAQ:ISPR) reported a 59.1% increase in Q3 revenue to $42.9 million, with cannabis vaping products revenue up 116.8% YoY to $17.3 million. Tobacco vaping products revenue rose 34.8% YoY to $25.5 million. Gross profit increased to $6.9 million, but gross margin decreased to 16.1%. Net loss narrowed to $1.38 million, and loss from operations decreased to $911,273. Operating expenses rose 29.8% to $7.8 million. The company's stock traded higher by 2.96% at $11.12 in pre-market.

Portfolio Pulse from Jelena Martinovic

November 14, 2023 | 8:07 pm

CVSI

CV Sciences, Inc. (OTCQB:CVSI), a wellness company specializing in hemp extracts, reported a revenue increase to $4.1 million in Q3 2023, up 9% from Q3 2022. Gross margin improved to 45.1%, and the company ended the quarter with a cash balance of $1.6 million. Positive cash flow from operations was $2.4 million, aided by a $2.5 million employee retention credit under the CARES Act. The company's shares were down 0.82% at $0.0302 per share.

Portfolio Pulse from Joana Scopel

November 14, 2023 | 8:03 pm

AGTI

Analysts have recently provided their opinions on Agiliti (NYSE:AGTI), with 1 bullish and 3 somewhat bearish ratings over the past 3 months. The average 12-month price target for AGTI is now $9.75, a significant decrease from the previous target of $14.75, indicating a potential downside of 33.9%. This change in target price reflects a more negative outlook from analysts.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 8:01 pm

WULF

TeraWulf (NASDAQ:WULF) has received 7 analyst ratings in the last quarter, with 3 being bullish and 4 somewhat bullish. There were no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for WULF is $3.57, with a high of $4.00 and a low of $3.00. This target has decreased by 20.67% from the previous target of $4.50. Analysts rate stocks based on future earnings potential and the predictability of a company's revenue streams.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 8:00 pm

AEM

CDE

EXK

FNV

FSM

GATO

GFI

GOLD

HMY

MUX

NEM

PAAS

SBSW

WPM

Precious metals stocks are trading higher as gold and silver prices increase due to a decline in the US dollar following the release of October CPI data.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:00 pm